News

CAF awards grant to UTHealth & UH for innovative research on imaging-based diagnostic and treatment

Boston - (June 2, 2010) – Cure Alzheimer’s Fund recently awarded the University of Texas Health Science Center at Houston (UTHealth) and the University of Houston a $150,000 grant to fund innovative research on Alzheimer’s disease, which currently affects 5.3 million Americans and their famili... (Read more)
Cure Alzheimer's Fun Awards Grant to University of Colorado School of Medicine

Boston – Cure Alzheimer’s Fund recently awarded Dr. Nicholas Seeds, with the University of Colorado School of Medicine, a $100,000 grant for novel research on Alzheimer’s disease, which affects 5.2 million Americans and their families and is the most common cause of dementia in the elderly. �... (Read more)
New Approach Yields Exciting Results on Origins of Alzheimer’s Disease: Testing of New Drug to Block Alzheimer's Causing Abeta42 Aggregation Underway

Boston -- A new approach developed for studying brain synapses has yielded valuable information about the production of Amyloid-Beta oligomers (clumps of the Abeta peptide) known to play a key role in the onset of Alzheimer’s disease. Published in the March 17 issue of the Journal of Neuroscience... (Read more)

McCance presents at Venture Summit East 2010

Henry McCance, Cure Alzheimer’s Fund co-founder and chairman emeritus, Greylock Partners, was a keynote speaker at Venture Summit East 2010. This two-day gathering highlighted the significant economic, political and technology trends impacting the global growth investor and was held at Harvard Bus... (Read more)
UPI: $150,000 Alzheimer's study grant awarded

Cure Alzheimer's Fund awarded the University of Texas Health Science Center and the University of Houston a $150,000 grant to fund important Alzheimer's research. The grant will give researchers the opportunity to accelerate their use of nanotechnology and new imaging techniques to study the effect... (Read more)
Cure Alzheimer’s Fund Pioneering Support of Oligomer Research Yielding Big Results

Cure Alzheimer's Fund's very own Dr. Sam Gandy is leading a team of researchers pioneering the support of oligomer research -- and they are seeing big results. According to Gandy's team of researchers, brain plaques -- long thought to be major cause of Alzheimer's -- may actually play a protective ... (Read more)

David Roscow
Tricom Associates
703-276-2772 x21
dave@tricomassociates.com

Cure Alzheimer's Fund: Targeting Breakthrough Research